NIOX Group (LON:NIOX) Shares Down 0.3% – Should You Sell?

NIOX Group Plc (LON:NIOX) shares dropped 0.3% on Monday . The stock traded as low as GBX 62.31 and last traded at GBX 62.80. Approximately 947,841 shares changed hands during trading, an increase of 19% from the average daily volume of 797,196 shares. The stock had previously closed at GBX 63.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft dropped their price target on NIOX Group from GBX 90 to GBX 86 and set a “buy” rating on the stock in a research report on Wednesday, January 21st. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, NIOX Group presently has a consensus rating of “Buy” and a consensus price target of GBX 88.

NIOX Group Stock Down 0.3%

The company has a market capitalization of £260.79 million, a price-to-earnings ratio of 49.92 and a beta of 0.92. The company has a current ratio of 3.73, a quick ratio of 1.94 and a debt-to-equity ratio of 1.86. The firm’s 50 day simple moving average is GBX 65.92 and its 200-day simple moving average is GBX 69.22.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.